Detection and function of opioid receptors on cells from the immune system.
作者信息
Bidlack J M
机构信息
Department of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester, Rochester, New York 14642, USA.
出版信息
Clin Diagn Lab Immunol. 2000 Sep;7(5):719-23. doi: 10.1128/CDLI.7.5.719-723.2000.
Abstract
摘要
相似文献
1
Detection and function of opioid receptors on cells from the immune system.
Clin Diagn Lab Immunol. 2000 Sep;7(5):719-23. doi: 10.1128/CDLI.7.5.719-723.2000.
2
Immunohistological detection of mu, delta and kappa opioid-like receptors in the gill, gonad, and hemocytes of the scallop Chlamys farreri.
Connect Tissue Res. 2010;51(1):67-70. doi: 10.3109/03008200903052118.
3
[The opioidergic system in the combined regulation of pain and immunity].
Izv Akad Nauk Ser Biol. 2001 May-Jun(3):339-52.
4
Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells.
Exp Cell Res. 2002 Nov 1;280(2):192-200. doi: 10.1006/excr.2002.5638.
5
An investigation of the N-demethylation of 3-deoxymorphine and the affinity of the alkylation products to mu, delta, and kappa receptors.
Bioorg Med Chem. 2004 May 15;12(10):2687-90. doi: 10.1016/j.bmc.2004.03.011.
6
Molecular pharmacology of the opioid receptors.
Pharmacol Ther. 1995;68(3):343-64. doi: 10.1016/0163-7258(95)02011-x.
7
Reporter affinity labels: an o-phthalaldehyde derivative of beta-naltrexamine as a fluorogenic ligand for opioid receptors.
J Med Chem. 2000 Jun 29;43(13):2489-92. doi: 10.1021/jm000138s.
8
The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
Biochemistry. 2000 Nov 14;39(45):13904-15. doi: 10.1021/bi001099p.
9
Interaction of local anaesthetics with recombinant mu, kappa, and delta-opioid receptors expressed in Chinese hamster ovary cells.
Br J Anaesth. 2000 Nov;85(5):740-6. doi: 10.1093/bja/85.5.740.
10
Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
Receptor. 1994 Spring;4(1):43-53.
引用本文的文献
1
Peripheral Opioid Receptors in the Modulation of Inflammatory Pain: a Narrative Review.
Maedica (Bucur). 2025 Mar;20(1):72-80. doi: 10.26574/maedica.2025.20.1.72.
2
Medications for opioid use disorder shape immune responses during chronic HIV infection.
Cell Rep Med. 2025 Jun 17;6(6):102159. doi: 10.1016/j.xcrm.2025.102159. Epub 2025 Jun 2.
3
Gender dependent modulation of opioid dependance genes and signaling pathways in HIV-1 Transgenic rats at morphine tolerance.
J Neurovirol. 2025 May 7. doi: 10.1007/s13365-025-01257-8.
4
Stereoselective Synthesis and Biological Evaluation of Perhydroquinoxaline-Based κ Receptor Agonists.
Int J Mol Sci. 2025 Jan 24;26(3):998. doi: 10.3390/ijms26030998.
5
Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study.
BMC Neurol. 2024 Sep 6;24(1):327. doi: 10.1186/s12883-024-03815-9.
6
Interactions Between Endogenous Opioids and the Immune System.
Adv Neurobiol. 2024;35:27-43. doi: 10.1007/978-3-031-45493-6_3.
7
PKA inhibition is a central step in D,L-methadone-induced ER Ca release and subsequent apoptosis in acute lymphoblastic leukemia.
Front Cell Dev Biol. 2024 Apr 24;12:1388745. doi: 10.3389/fcell.2024.1388745. eCollection 2024.
8
CC Chemokine Family Members' Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury-A Review of Clinical and Experimental Findings.
Int J Mol Sci. 2024 Mar 28;25(7):3788. doi: 10.3390/ijms25073788.
9
Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain.
Molecules. 2023 Jul 30;28(15):5766. doi: 10.3390/molecules28155766.
10
Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal.
Viruses. 2023 Feb 1;15(2):415. doi: 10.3390/v15020415.
本文引用的文献
1
Mitogen-induced activation of mouse T cells increases kappa opioid receptor expression.
Adv Exp Med Biol. 2001;493:103-10. doi: 10.1007/0-306-47611-8_12.
2
Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation.
J Pharmacol Exp Ther. 1999 Aug;290(2):863-70.
3
The opioid-cytokine connection.
J Neuroimmunol. 1998 Mar 15;83(1-2):63-9. doi: 10.1016/s0165-5728(97)00222-1.
4
Opiate binding sites in the cellular immune system: expression and regulation.
J Neuroimmunol. 1998 Mar 15;83(1-2):57-62. doi: 10.1016/s0165-5728(97)00221-x.
5
Evidence for opioid receptors on cells involved in host defense and the immune system.
J Neuroimmunol. 1998 Mar 15;83(1-2):45-56.
6
Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry.
J Pharmacol Exp Ther. 1998 Jan;284(1):298-306.
7
Detection of basal levels and induction of delta opioid receptor mRNA in murine splenocytes.
J Neuroimmunol. 1997 Sep;78(1-2):198-202. doi: 10.1016/s0165-5728(97)00101-x.
8
Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin.
J Immunol Methods. 1997 Feb 28;201(2):173-81. doi: 10.1016/s0022-1759(96)00223-2.
9
Morphine affects the brain-immune axis by modulating an interleukin-1 beta dependent pathway.
Adv Exp Med Biol. 1996;402:35-42. doi: 10.1007/978-1-4613-0407-4_6.
10
kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression.
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8051-6. doi: 10.1073/pnas.93.15.8051.
Zotero 插件